» Articles » PMID: 17483061

Bacterial Bloodstream Infection in Neutropenic Adult Patients After Myeloablative Cord Blood Transplantation: Experience of a Single Institution in Japan

Overview
Journal Int J Hematol
Specialty Hematology
Date 2007 May 8
PMID 17483061
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Bacterial infection is one of the most important causes of morbidity and mortality after unrelated cord blood transplantation (CBT). In the present study, we studied 101 adult patients with respect to the incidence, outcome, and risk factors for bacterial bloodstream infection (BSI) within 30 days after CBT using a myeloablative conditioning regimen. Bacterial BSI occurred in 12 patients within 30 days after CBT. The cumulative incidence of bacterial BSI was 12%. The median time of onset was day +6 (range, day -1 to day +13) after CBT. In all patients, the neutrophil count was 0/microL at the onset of bacterial BSI. Eight (67%) and 4 (33%) of the isolates were Gram-positive and Gram-negative bacteria, respectively. Only 2 (17%) of the 12 patients who had bacterial BSI died within 100 days after CBT. No risk factors for the occurrence of bacterial BSI within 30 days after CBT were identified. The low mortality rate for bacterial BSI in the neutropenic period appeared to be associated with the low incidence (6%) of transplantation-related death at day +100 in our study patients. Early diagnosis of bacterial BSI and prompt treatment with effective antibiotics are necessary for neutropenic adult patients after myeloablative CBT.

Citing Articles

Clinical implications of augmented renal clearance after unrelated single cord blood transplantation in adults.

Konuma T, Takano K, Monna-Oiwa M, Isobe M, Kato S, Takahashi S Int J Hematol. 2023; 118(6):718-725.

PMID: 37851311 PMC: 10673748. DOI: 10.1007/s12185-023-03669-w.


Incidence, Etiology, Risk Factors, and Outcomes of Bloodstream Infection after a Second Hematopoietic Stem Cell Transplantation.

Ohta T, Ueno T, Uehara Y, Yokoyama T, Nakazawa M, Sato Y Intern Med. 2023; 62(22):3305-3316.

PMID: 37032079 PMC: 10713375. DOI: 10.2169/internalmedicine.1666-23.


The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study.

Ge J, Yang T, Zhang L, Zhang X, Zhu X, Tang B BMC Infect Dis. 2018; 18(1):654.

PMID: 30545330 PMC: 6293544. DOI: 10.1186/s12879-018-3575-x.


Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated Donors.

Montoro J, Pinana J, Moscardo F, Sanz J Mediterr J Hematol Infect Dis. 2016; 8(1):e2016051.

PMID: 27872731 PMC: 5111514. DOI: 10.4084/MJHID.2016.051.

References
1.
Hughes W, Armstrong D, Bodey G, Bow E, Brown A, Calandra T . 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002; 34(6):730-51. DOI: 10.1086/339215. View

2.
Saavedra S, Sanz G, Jarque I, Moscardo F, Jimenez C, Lorenzo I . Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant. 2002; 30(12):937-43. DOI: 10.1038/sj.bmt.1703764. View

3.
Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A . Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004; 351(22):2276-85. DOI: 10.1056/NEJMoa041469. View

4.
Narimatsu H, Matsumura T, Kami M, Miyakoshi S, Kusumi E, Takagi S . Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant. 2005; 11(6):429-36. DOI: 10.1016/j.bbmt.2005.01.010. View

5.
Hamza N, Lisgaris M, Yadavalli G, Nadeau L, Fox R, Fu P . Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol. 2004; 124(4):488-98. DOI: 10.1046/j.1365-2141.2003.04792.x. View